Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of seattle heart failure score

American Journal of Cardiology

Volumn 107, Issue 6, 2011, Pages 938-944

  Raposeiras Roubín, Sergio ^a,b   Rodiño Janeiro, Bruno K ^a,b   Grigorian Shamagian, Lilian ^b,c   Moure González, María ^a   Seoane Blanco, Ana ^a   Varela Román, Alfonso ^a   Almenar Bonet, Luis ^d   Álvarez, Ezequiel ^b,e   González Juanatey, José R ^a,b,e  

^a Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

^b Instituto de Investigación Sanitaria de Santiago de Compostela IDIS   (Spain)

^c HOSPITAL DO MEIXOEIRO   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DYSLIPIDEMIA; FEMALE; HEART DEATH; HEART FAILURE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; SEATTLE HEART FAILURE SCORE; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

AGED; ANALYSIS OF VARIANCE; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPAIN;

EID: 79952315772     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.11.011     Document Type: Article

References (18)

1. M. Brownlee Negative consequences of glycation Metabolism 49 2000 9 13 (Pubitemid 30091786)
2. S. Mak, and G.E. Newton The oxidative stress hypothesis of congestive heart failure: radical thoughts Chest 120 2001 2035 2046 (Pubitemid 34053470)
3. G. Basta, G. Lazzerini, M. Massaro, T. Simoncini, P. Tanganelli, C. Fu, T. Kislinger, D.M. Stern, A.M. Schmidt, and R. De Caterina Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses Circulation 105 2002 816 822 (Pubitemid 34174921)
4. J.M. Zimmet, and J.M. Hare Nitroso-redox interactions in the cardiovascular system Circulation 114 2006 1531 1544 (Pubitemid 44527009)
5. S.F. Yan, R. Ramasamy, and A.M. Schmidt The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature Circ Res 106 2010 842 853
6. S. Yamagishi, H. Adachi, K. Nakamura, T. Matsui, Y. Jinnouchi, K. Takenaka, M. Takeuchi, M. Enomoto, K. Furuki, A. Hino, Y. Shigeto, and T. Imaizumi Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects Metabolism 55 2006 1227 1231 (Pubitemid 44215942)
7. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, A.B. Cropp, I. Anand, A. Maggioni, P. Burton, M.D. Sullivan, B. Pitt, P.A. Poole-Wilson, D.L. Mann, and M. Packer The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433 (Pubitemid 43739439)
8. G. Giamouzis, A.P. Kalogeropoulos, V.V. Georgiopoulou, S.A. Agha, M.A. Rashad, S.R. Laskar, A.L. Smith, and J. Butler Incremental value of renal function in risk prediction with the Seattle Heart Failure Model Am Heart J 157 2009 299 305
9. H.T. May, B.D. Horne, W.C. Levy, A.G. Kfoury, K.D. Rasmusson, D.T. Linker, D. Mozaffarian, J.L. Anderson, and D.G. Renlund Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide Am J Cardiol 100 2007 697 700 (Pubitemid 47223146)
10. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, P.A. Poole-Wilson, A. Stromberg, D.J. van Veldhuisen, D. Atar, A.W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S.G. Priori, K. Swedberg, A. Vahanian, J. Camm, R. De Caterina, V. Dean, C. Funck-Brentano, I. Hellemans, S.D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J.L. Zamorano, A. Auricchio, J. Bax, M. Bohm, U. Corra, P. della Bella, P.M. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J.L. Vachiery, F.W. Verheugt, and F. Zannad ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
11. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, S. Hendriksen, J.W. Kusek, and F. Van Lente Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254 (Pubitemid 46768608)
12. G. Munch, R. Keis, A. Wessels, P. Riederer, U. Bahner, A. Heidland, T. Niwa, H.D. Lemke, and R. Schinzel Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA Eur J Clin Chem Clin Biochem 35 1997 669 677
13. J.B. Lindsey, F. Cipollone, S.M. Abdullah, and D.K. McGuire Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications Diabetes Vasc Dis Res 6 2009 7 14
14. S. Raposeiras-Roubn, B.K. Rodino-Janeiro, L. Grigorian Shamagian, M. Moure-Gonzlez, A. Seoane-Blanco, A. Varela-Roman, E. lvarez, and J.R. Gonzlez-Juanatey Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels Eur J Heart Fail 12 2010 1092 1100
15. Y. Koyama, Y. Takeishi, T. Niizeki, S. Suzuki, T. Kitahara, T. Sasaki, and I. Kubota Soluble Receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure J Card Fail 14 2008 133 139 (Pubitemid 351312887)
16. A. Lapolla, R. Reitano, R. Seraglia, G. Sartore, E. Ragazzi, and P. Traldi Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress Mol Nutr Food Res 49 2005 685 690 (Pubitemid 41008206)
17. R. Petrova, Y. Yamamoto, K. Muraki, H. Yonekura, S. Sakurai, T. Watanabe, H. Li, M. Takeuchi, Z. Makita, I. Kato, S. Takasawa, H. Okamoto, Y. Imaizumi, and H. Yamamoto Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes J Mol Cell Cardiol 34 2002 1425 1431 (Pubitemid 35244419)
18. R. Pfister, H. Diedrichs, A. Schiedermair, S. Rosenkranz, M. Hellmich, E. Erdmann, and C.A. Schneider Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients Eur J Heart Fail 10 2008 315 320